Show simple item record

dc.creatorButtar, Aliyaen_US
dc.creatorSeward, Sheradenen_US
dc.date.accessioned2012-05-10T14:01:55Z
dc.date.available2012-05-10T14:01:55Z
dc.date.created2008-09-04en_US
dc.date.issued2012-05-10
dc.identifier.otherembryo:125450en_US
dc.identifier.urihttp://hdl.handle.net/10776/1944
dc.description.abstractPlan B is a progestin-only emergency contraceptive pill (ECP) that can be taken within seventy-two hours of unprotected sex in order to prevent an unwanted pregnancy. Plan B was created in response to the United States Food and Drug Administration's (US FDA) 1997 request for new drug applications (NDAs) for a dedicated ECP product, and was approved for sales in the US in 1999. Duramed, a subsidiary of Barr Pharmaceuticals, manufactures Plan B for The Women's Capital Corporation (WCC), which owns the patent for Plan B. This technology is important in part because it expands women's reproductive rights by giving them greater control over their fertility. The mechanism of action of Plan B also raises questions about the moral status of the zygote.en_US
dc.format.mediumtext/xhtmlen_US
dc.language.isoengen_US
dc.publisherArizona State University. School of Life Sciences. Center for Biology and Society. Embryo Project Encyclopedia.en_US
dc.relation.ispartofEmbryo Project Encyclopediaen_US
dc.rights© Arizona Board of Regentsen_US
dc.subjectTechnologyen_US
dc.subject.meshContraceptionen_US
dc.titlePlan B: Emergency Contraceptive Pillen_US
dc.typeTexten_US
dc.rights.licenseLicensed as Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported (CC BY-NC-SA 3.0) http://creativecommons.org/licenses/by-nc-sa/3.0/
dc.subject.embryoTechnologiesen_US
dc.subject.embryoReproductionen_US
dc.subject.tagContraceptionen_US
dc.subject.tagReproductive rightsen_US
dc.description.typeArticlesen_US
dc.date.createdstandard2008-09-04


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record